10, Jan 2025
Lenalidomide Pricing in the US
The cost of Lenalidomide in the United States can vary significantly depending on factors such as the dosage, insurance coverage, and pharmacy location. On average, the Lenalidomide Cost can be quite high, making it a financial burden for many patients, particularly those without adequate insurance. Assistance programs and generic alternatives may help reduce expenses for eligible individuals.
Lenalidomide Pricing in the US: An In-Depth Analysis
Lenalidomide Cost is the third-largest revenue-generating pharmaceutical product worldwide, earning Celgene and Bristol Myers Squibb $53 USD billion between 2009 and 2018. This case study examines how these companies used a US Food and Drug Administration (FDA)-mandated patient safety program—the Risk Evaluation and Mitigation Strategy or REMS—to avoid generic competition and preserve blockbuster status for this medicine. It highlights business practices common to all manufacturers investigated by the House Oversight Committee and strategies unique to lenalidomide, which offer insights into ways to reform drug pricing policies.
- 0
- By jonesmosley
